Orlistat

Gout

XueMei GuoSmall moleculeN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 89/ 100

Competitive context

4 Active assets in the Gout cohort.

Asset / Sponsor	Phase	Rating
Febuxostat Haiphong University of Medicine and Pharmacy	Phase 4	BBB
Allopurinol Haiphong University of Medicine and Pharmacy	Phase 4	B
Metformin Mostafa Bahaa	Phase 2	CCC
Abp-745 Atom Therapeutics Co., Ltd	Phase 1	CC
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Express Specialty Pharmacy		D

View all 19 →

Same molecule, other indications

Orlistat is also rated in:

type 2 diabetes mellitusDormant

BBB

Indicative ·

73 / 100

polycystic ovary syndromeDormant

BB

Indicative ·

70 / 100

obesity disorderDormant

BB

Indicative ·

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.